Chronic Toxic Effects Following Adjuvant Anti–PD-1 Therapy for High-Risk Resected Melanoma
25/3/2021
0:00
17:39
Interview with Douglas B. Johnson, MD, author of Chronic Immune-Related Adverse Events Following Adjuvant Anti–PD-1 Therapy for High-risk Resected Melanoma
Otros episodios de "JAMA Oncology Author Interviews"
No te pierdas ningún episodio de “JAMA Oncology Author Interviews”. Síguelo en la aplicación gratuita de GetPodcast.